---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-030804"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T12:50:01.272425+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Aquestive shareholders elect two Class I directors, approve say-on-pay, ratify KPMG at 2025 annual meeting

## Summary
- Daniel Barber and Timothy E. Morris elected as Class I directors with 36,060,882 and 35,562,599 votes for, respectively.
- Non-binding advisory vote on executive compensation approved: 32,454,278 for, 6,694,084 against, 459,188 abstain.
- Ratification of KPMG as independent auditor for FY 2025 passed: 66,530,646 for, 1,166,766 against.
- Broker non-votes of 29,848,112 on director elections and say-on-pay proposal.
- Annual Meeting held June 11, 2025; results reported under Item 5.07.

## SEC filing metadata
- accession: 0001628280-25-030804
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828025030804/0001628280-25-030804-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828025030804/aqst-20250611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-030804
- JSON: https://secwatch.observer/filing/0001628280-25-030804.json
- Plain text: https://secwatch.observer/filing/0001628280-25-030804.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.